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The widespread rollout of treatment for HIV/AIDS in the 
developing world has brought into stark relief the shortage 
of trained health care workers available to implement 
interventions and mount successful public health campaigns.  
HIV/AIDS in the health care workforce challenges the success 
of both general and AIDS-related health care investments by 
reducing the productivity of HIV-positive health care workers, 
increasing labour turnover, diminishing the average level of 
work experience, and driving up costs for public sector health 
budgets.  For local and national departments of health and 
individual facility managers to formulate an effective response 
to AIDS in the health care workforce, an accurate assessment is 
needed of the prevalence of HIV infection and the proportion 
of infected workers who are at risk of opportunistic infections 
(OIs) and who should be on antiretroviral therapy (ART).
In South Africa, one of the countries hardest hit by the global 
AIDS epidemic, national HIV prevalence among working-
aged adults is estimated at 16.2%.1 In Gauteng, the location 
of the current study, adult prevalence was estimated at 15.8% 
in 2005.1 A year earlier, a prevalence study using a cluster 
sample methodology estimated the HIV prevalence among 
public hospital employees in South Africa at 11% nationwide, 
although the study was limited by small sample size and low 
participation.2 In Gauteng, prevalence among public hospital 
employees was estimated to be 15.9%, nearly identical to that 
found in the adult population as a whole.2  
Although HIV seroprevalence surveys can provide a 
general picture of the extent of the epidemic in a population, 
information on disease progression is needed for planning 
and budgeting a programmatic response.  Since disease 
progression within an HIV-positive population is likely to vary 
with epidemic maturity, progression in South Africa, where 
the AIDS epidemic is relatively young, may not resemble that 
found in other countries.  We located only two population-
based studies that measured CD4 counts among asymptomatic 
HIV-positive individuals in South Africa.  In a South African 
township in Gauteng in 2002, 9.5% of HIV-positive adults had 
a CD4 count below 200 cells/µl, and 28.4% had a CD4 count 
below 350 cells/µl.3 A recent survey4,5 of South African teachers 
found that 22% of HIV-positive respondents had CD4 counts 
below 200 cells/µl and 52% had CD4 counts below 350 cells/
µl.  No data on disease progression are available for health care 
workers, whose level of health education, access to health care,
Prevalence of HIV infection and median CD4 counts among 
health care workers in South Africa
Daniela Connelly, Youssef Veriava, Sue Roberts, Josephine Tsotetsi, Annie Jordan, Eliot DeSilva, Sydney Rosen,   
Mary Bachman DeSilva
Boston University School of Public Health, Center for International Health and 
Development, Boston, Massachusetts, USA
Daniela Connelly, MD, MPH
Sydney Rosen, MPA
Mary Bachman DeSilva, ScD, MS
Helen Joseph Hospital, Johannesburg
Youssef Veriava, MD
Sue Roberts, RN
Josephine Tsotetsi, RN
Coronation Hospital, Johannesburg
Annie Jordan, RN
Cambridge Hospital, Cambridge, Massachusetts, USA
Eliot DeSilva, MD, MPH
Corresponding author: Mary Bachman DeSilva (marybd@bu.edu)
Objective. To determine the prevalence of HIV infection and the 
extent of disease progression based on CD4 count in a public 
health system workforce in southern Africa.
Design. Cross-sectional voluntary, anonymous, unlinked survey 
including an oral fluid or blood sample and a brief demograph-
ic questionnaire.
Setting. Two public hospitals in Gauteng, South Africa.
Subjects. All 2 032 professional and support staff employed by 
the two hospitals.
Outcome measures. HIV prevalence and CD4 cell count distribu-
tion.
Results. Overall prevalence of HIV was 11.5%.  By occupa-
tion, prevalence was highest among student nurses (13.8%) 
and nurses (13.7%).  The highest prevalence by age was in the 
25 - 34-year group (15.9%). Nineteen per cent of HIV-positive 
participants who provided blood samples had CD4 counts less 
than or equal to 200 cells/µl, 28% had counts 201 - 350 cells/µl, 
18% had counts 351 - 500 cells/µl, and 35% had counts above 
500 cells/µl.
Conclusions. One out of 7 nurses and nursing students in this 
public sector workforce was HIV-positive.  A high proportion 
of health care workers had CD4 counts below 350 cells/µl, and 
many were already eligible for antiretroviral therapy under 
South African treatment guidelines. Given the short supply 
of nurses in South Africa, knowledge of prevalence in this 
workforce and provision of effective AIDS treatment are crucial 
for meeting future staffing needs. 
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and exposure to infectious diseases differ from those of other 
populations.
To provide relevant, practical information to hospital 
managers and health department policy makers, we measured 
the prevalence of HIV and the extent of disease progression 
based on CD4 cell counts among health care workers at two 
public hospitals in an urban area of Gauteng, South Africa. 
This article reports on prevalence of HIV infection in the 
workforce and the distribution of CD4 cell counts among HIV-
positive health care workers.  
Methods
Study sites and population
The study was conducted at Helen Joseph and Coronation 
hospitals, two jointly managed public hospitals of the Gauteng 
Department of Health.  Helen Joseph Hospital provides 
outpatient clinical care, secondary care, and tertiary care in 
surgery, orthopaedics, psychiatry, and internal medicine; 
Coronation Hospital offers clinical care in paediatrics, 
gynaecology, and obstetrics to the same patient base.  The 
study population included all 2 032 professional and support 
staff at the two hospitals. For the purposes of this study, 
professional staff were defined as medical doctors, nurses, 
assistant nurses, nursing students, and allied health care 
workers (pharmacists, psychologists, occupational therapists, 
social workers, and other professionals at the same level).  
Support staff included maintenance, cleaning and kitchen 
staff known as general assistants.  All hospital employees who 
attended work on at least 1 of the test days were included in 
the study.  Employees who were absent from work on all test 
days were excluded, as were hospital volunteers and security 
personnel employed by an outside contractor because their 
attendance could not be verified on the hospitals’ human 
resource rosters.  HIV counsellors were excluded because many 
were deliberately recruited from the HIV clinic’s patient pool. 
Procedures
Data for this study were collected in February 2005 using 
a cross-sectional, voluntary, anonymous, unlinked survey 
comprising two parts: (i) an oral fluid or blood sample 
taken from each participant; and (ii) a brief demographic 
questionnaire completed by each participant.  No sampling 
was done; the goal was to test all employees in attendance at 
work on the data collection days.  Both the oral fluid sample 
and blood sample options were offered to each participant 
in order to maximise participation.  The demographic 
questionnaire was completed in a brief face-to-face encounter 
between research staff and each participant.  Participation 
was purely voluntary.  No monetary compensation was 
provided, but each participant received a T-shirt as a token of 
appreciation for his/her time and potential discomfort.
Building on previous experience with private sector 
workforce surveys in South Africa, extensive efforts were made 
to ensure that the prospective participants: (i) understood 
the purpose, benefits, risks, and voluntary nature of the 
survey; (ii) were comfortable with the steps taken to ensure 
anonymity and confidentiality; and (iii) were willing to 
participate.  Information was provided via posters, letters, and 
staff meetings.  A series of meetings was held with hospital 
stakeholders (managers, human resource staff, ward matrons, 
and workers’ union representatives) to answer questions and 
solicit suggestions regarding the implementation of the survey.  
One of the key messages communicated to participants was 
that they would not be able to obtain their HIV results from 
this survey since it was entirely unlinked and anonymous, but 
that they would be informed of where to obtain free voluntary 
counselling and testing (VCT) if they wished to know their 
HIV status.
The Medical Research Ethics Committee of the University of 
the Witwatersrand provided ethical approval for the study.  
Data collection and laboratory analysis
Samples were collected at each study site from 09h00 to 
14h00 on 4 consecutive days and also from 19h00 to 21h00 
on 2 consecutive nights, thus giving night shift staff an 
opportunity to participate.  Samples were collected using 
the OraSure collection device (OraSure Technologies, 
Bethlehem, Pennsylvania, USA) or by means of phlebotomy.  
In cases where blood was drawn, 2 vacutainers of 2 ml 
each were collected per volunteer, one for enzyme-linked 
immunosorbent assay (ELISA) testing and the other for CD4 
testing.  Phlebotomists from outside the two study hospitals 
drew the blood samples.  Each participant was also asked to 
provide basic demographic information on a form filled out 
by a member of the research team.  Information was limited 
to four demographic variables: gender (male or female), age 
range (18 - 24, 25 - 34, 35 - 44, 45 - 54, 55 years and older), 
professional level (medical officer, nurse, allied staff, or general 
assistant), and ethnic designation (black, coloured, white or 
Asian, which are the official descriptors used in South Africa).  
No individual identifiers such as employee or ID number, 
name or address were collected.  Samples and questionnaires 
for each participant were marked with an identical computer 
bar code and deposited in a large container at the entrance 
to the testing room so that participants could see that the 
process was genuinely anonymous.  Research study staff were 
available to assist with sample collection, answer questions as 
needed, discourage repeat participation, and prevent ineligible 
individuals from giving samples.
Oral fluid specimens were stored at room temperature, 
and blood samples at between 10°C and 15°C.  Both types 
of specimens were transported to the Contract Laboratory 
Services (CLS) of the National Health Laboratory Services 
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(NHLS) laboratory in Johannesburg at approximately 2-hour 
intervals, with the exception of samples collected at night 
which were transferred to the laboratories within 9 hours.  Both 
oral fluid and blood samples were tested using the ELISA HIV-
1 and HIV-2 antibody tests. Blood samples were then processed 
further to determine CD4 cell count.  
To determine the participation rate for the survey at each 
site, employee attendance records were collected for each 
day and night of the survey to generate a complete roster of 
employees who were at work during the 3-day period and 
who could therefore potentially have participated.  Attendance 
records were cross-checked with human resources records.  
Employees who were absent for any reason (scheduled 
vacations, maternity leave, study leave, sick leave, etc.) on 
all test days or nights were excluded from the analysis. All 
employees in attendance on at least 1 day or night comprised 
the participation denominator; all those who were tested were 
included in the numerator.  
Statistical analysis
HIV test results and questionnaire responses were entered 
into an Excel database at the laboratory and sent to the 
lead researcher (DC) for analysis.  Sample containers and 
questionnaires were matched using duplicate bar codes.  
Univariate analysis was used to calculate the prevalence of 
HIV infection in the study population as a whole and median 
CD4 count.  Results were then stratified into subgroups by sex, 
age range, race and job level.  Chi-square tests were used to 
determine differences in HIV prevalence between subgroups.  
Kruskal-Wallis tests were used to assess differences in median 
CD4 counts.  All data were analysed using Statistical Analysis 
System (SAS) software version 9.1 (SAS Institute, Cary, North 
Carolina, USA).  
Results
Of the 2 032 health care workers employed by the two 
hospitals, 1 813 (89.2%) attended work on at least one day 
or night of the study period and were therefore eligible 
to participate in the survey.  Of the eligible population, 1 
522 (83.9%) volunteered to be tested (Table I); 82.3% (1 493 
individuals) provided complete demographic questionnaire 
data and comprised our analytical sample.  The overall 
participation rate increases to 89.5% if doctors are excluded.  
Of the 1 493 individuals in the analytic sample, 788 (53%) 
provided blood samples and 705 (47%) oral fluid samples.  
Reflecting the gender distribution at the two hospitals, the 
overwhelming majority (88%) of the employees tested were 
female.  Characteristics of the health care workers tested are 
reported in Table I.
The overall HIV prevalence in the tested population was 
11.5% (Table I).  By job level, prevalence was highest among 
student nurses (13.8%) and nurses (13.7%).  Consistent with 
population trends in South Africa, women were more likely to 
be HIV-positive than men (12.0% v. 7.9%), but the difference 
Table I. HIV prevalence among health workers stratified by sociodemographic characteristics, Coronation and Helen Joseph 
Hospitals, 2005
       
          Available (N)                Tested with complete Response  
          for testing                demographic data (N) rate (%)              HIV-positive (N) Prevalence (%)
Overall              1 813              1 493     82.3          172         11.5
Job category      
Medical doctors                200                   49     24.5              1           2.0
Allied staff                278                 247     88.8            14           5.7
Nurses                 708                 644     91.0            88                        13.7
Student nurses                  66                   65     98.5              9         13.8
General assistants               561                 488     87.0            60         12.3
Gender     
Female                         1 315            158         12.0
Male                            178              14           7.9
Age (years)     
18 - 24                           105                7           6.7
25 - 34                            327              52         15.9
35 - 44                            530              69         13.0
45 - 54                            393              40         10.2
55+                            138                4           2.9
Racial group     
Black                         1 028            156         15.2
Coloured                           318              15           4.7
Asian                              42                1           2.4
White                             105                 0           0.0
Pg 115-123.indd   117 1/19/07   1:54:34 PM
February 2007, Vol. 97, No. 2  SAMJ
ORIGINAL ARTICLES
118
was not statistically significant (p = 0.10).  Prevalence was 
highest in the 25 - 34-year age group (15.9%) and among black 
participants (15.0%).  
Table II stratifies HIV prevalence by age and occupation; the 
analysis is limited somewhat by small cell sizes.  Seventy-four 
of 172 HIV-positive workers (43%) provided blood samples 
for CD4 testing.  Although there was a higher HIV prevalence 
among those who provided oral fluid samples than among 
those who gave blood (13.6% v. 9.6%, p = 0.0104), there were 
few demographic differences between the HIV-positive 
participants who gave blood rather than oral fluid, except 
that a smaller proportion of HIV-positive nurses and a larger 
proportion of HIV-positive general assistants gave blood (data 
not shown).  Small cell sizes prevented statistical assessment 
of differences in other characteristics.  The median CD4 cell 
count among HIV-positive participants was 397 (69 - 1 359) 
cells/µl, and the median CD4 cell count among HIV-negative 
participants was 1 036 (266 - 2 815) cells/µl.  Based on CD4 cell 
count, the distribution of disease progression was as follows: 
14 (19%) of the HIV-positive participants had CD4 counts less 
than or equal to 200 cells/µl, 21 (28%) had counts 201 - 350 
cells/µl, 13 (18%) had counts 351 - 500 cells/µl, and 26 (35%) 
had counts above 500 cells/µl (Table III).  
Discussion
This study estimated the prevalence of HIV infection and the 
extent of disease progression based on CD4 counts among 
health care workers at two local hospitals in Gauteng. The 
overall prevalence for this population was 11.5%, with nearly 
20% of those who tested HIV-positive already eligible for ART 
at the time of the survey and almost 30% more approaching 
that stage. 
Table II. HIV prevalence among health workers stratified by occupation and age, Coronation and Helen Joseph hospitals
Age (years)            Tested (N)     HIV-positive (N)       Prevalence (%)
   
Allied staff   
18 - 24    30   1   3.3
25 - 34    55   2   3.6
35 - 44    96   6   6.3
45 - 54    54   5   9.3
55+    12   0   0.0
General assistants   
18 - 24      3   0   0.0
25 - 34    13   3                 23.1
35 - 44                  154                 28                 18.2
45 - 54                  225                 26                 11.6
55+    93                  3   3.2
Nurses   
18 - 24    35   3   8.6
25 - 34                  214                 43                 20.1
35 - 44                  255                 32                 12.5
45 - 54                  111   9   8.1
55+                   29   1   3.4
Student nurses   
18 - 24    29   3   10.3
25 - 34    23   4   17.4
35 - 44    12   2   16.7
45 - 54      1   0     0.0
55+      0   0        -
Table III. CD4 cell counts (/µl) among HIV-positive health workers, Coronation and Helen Joseph hospitals, 2005*
Stage    Number of persons    Percent of total
≤ 200                  14             18.9
201 - 350                  21             28.4
351 - 500                  13             17.6
> 500                  26             35.1
Total                  74           100.0
* Overall mean = 451, standard deviation = 286, median = 397.
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Our study gathered data directly from a contained and 
defined population, avoiding sampling biases by attempting 
to test the whole population.  With a participation rate of 
82% (90% if physicians are excluded), it is unlikely that we 
missed any large trends.  We may have underestimated HIV 
prevalence if the workers who were absent from work and 
therefore excluded from the survey were more likely to be 
infected, as may well have been the case for those on sick 
or bereavement leave.  Within the HIV-positive population, 
those absent on sick leave may have had more advanced 
disease than those who were able to attend work.  Because 
participants could choose between providing a blood sample 
and an oral fluid sample, it is possible that our CD4 cell count 
staging results could suffer from self-selection bias (e.g. if 
HIV-positive employees at more advanced disease stages were 
either more or less likely to provide a blood sample because of 
knowledge of their HIV status).  We were not able to assess this 
statistically.  
The overall prevalence estimated in our study is substantially 
lower than estimates made for other adult populations in South 
Africa, such as the 16% prevalence estimated for both all adults 
in Gauteng and among the health workforce nationwide.2 
The main exception is the national survey of educators 
conducted in 2004, which estimated a 6.4% prevalence among 
teachers in Gauteng and 12.7% in South Africa overall.4,5 The 
national health care worker study2 used broad age bands and 
reported 20.0% prevalence in the 18 - 35-year age band and 
16.6% in the 36 - 45-year age band.  Our study found little 
difference between the age bands when we aggregated by 
broad age bands.  It is unclear why our results are generally 
lower than other estimates within the general South African 
population, but the difference may be related in part either to a 
different socio-economic profile or to the success of prior HIV 
prevention efforts in Gauteng or at these two facilities.  Our 
result is comparable to studies of other workforces in Gauteng 
which have estimated prevalence in the region of 5 - 15%6 (and 
Colvin M, Connolly C, Madurai L – unpublished research).
There is little published on how prevalence may vary 
among different segments of the health workforce. Wilkinson 
and Gilks7  found no difference in incidence of tuberculosis 
(TB) between health professionals and ancillary staff.  In the 
South African Human Sciences Research Council (HSRC) 
health care worker study,2 non-professional health care 
workers had a prevalence of 20.3% compared with 13.7% 
among professionals. We did not find a significant difference 
in prevalence between professional staff (11.1%) and non-
professional staff (12.3%) (data not shown). 
Perhaps the most concerning of our findings is the high 
prevalence of HIV infection among nursing students.  Nursing 
students are already in short supply in South Africa and are 
urgently needed to fill vacant nursing posts.  Given the extent 
of HIV infection among nurses, even more students will 
have to be recruited.  Training of nurses also requires a large 
investment of public resources.  High HIV prevalence, and 
therefore high impending morbidity and mortality, among 
nursing students is very bad news and should cause nursing 
school faculty to take notice.   
In terms of disease progression, among those health care 
workers who tested positive for HIV and provided blood 
samples, many had advanced disease, with a median CD4 
count of 397 cells/µl.  In our study, 18.9% of health care 
workers who tested positive for HIV had CD4 cell counts 
less than or equal to 200 cells/µl, making them eligible for 
treatment according to both World Health Organization and 
South African national treatment guidelines.8,9  Moreover, 
nearly half of HIV-positive employees had a CD4 count less 
than or equal to 350 cells/µl.  The percentage of individuals 
eligible for ART may therefore actually be higher, since HIV-
positive health care workers with CD4 counts between 200 and 
350 cells/µl may have AIDS-defining opportunistic infections 
that make them eligible for treatment.
Documenting HIV prevalence within a given health facility 
and the proportion of those infected who are at risk of higher 
morbidity has several important implications.  First is the 
question of who is responsible for protecting HIV-positive 
health care workers from being exposed to potentially fatal 
opportunistic infections like TB.  Does the onus lie on the 
employee to: (i) know his/her HIV status, and (ii) if positive, 
maintain his/her CD4 cell count above 350 cells/µl, or should 
the public health sector devise strategies to encourage workers 
to ask to be removed from high-risk clinical wards because 
of their HIV status?  A second implication of many workers 
having CD4 cell counts 350 cells/µl or below is that there 
is a need for accessible, efficient HIV clinical management 
and access to ART for these employees.   Third, the fact that 
approximately 20% of HIV-positive workers in our sample 
have AIDS, including 20% of HIV-positive nursing students 
and nurses under age 35, suggests that the public sector must 
improve efforts to secure the supply of future health staff.10
The benefits of ascertaining the HIV prevalence within a 
health facility can be immediate and tangible. An unanticipated 
result of our study was that, at the request of HIV-positive 
employees, the study hospitals established an HIV clinic 
solely for health care workers.  Health care workers can obtain 
confidential counselling, testing, and treatment for HIV/AIDS 
on site during working hours without enduring very long 
waits in outpatient lounges.  Since the opening of this service, 
more than 60 staff have enrolled in the in-house HIV clinic.  
Only when the extent of the problem was understood could 
management and unions formulate appropriate strategies for 
care and support of HIV-positive health care workers.  
The authors wish to acknowledge the invaluable collaboration 
by the hospital administrators, head nurses (matrons), and union 
representatives, and the extraordinary participation of the hospital 
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employees.  The South African National Departments of Health 
and Social Development and the Gauteng Department of Health 
and the Employees Wellness Program (EWP) also provided 
important support.
This project was funded by the Foreign Assistance Agencies 
of Australia (AusAID), the UK (DFID), and the United States 
of America (USAID), and by the United Nations Development 
Programme (UNDP) of South Africa. Technical assistance was 
provided by the Joint Economics AIDS and Poverty Programme 
(JEAPP), an affiliate of the African Asian Society (AAS).
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Carcinoma of the cervix is the commonest genital malignancy 
afflicting women in the developing world. An estimated 190 
000 women die each year as a result of cervical cancer, with 
80% of these deaths occurring in the developing world.1 
Rates are highest in central America, sub-Saharan Africa and 
Melanesia, making it one of the most important reproductive 
health problems of public health importance in these regions. 
Cervical cancer is preventable by instituting cervical cytological 
screening and treatment of early lesions. In countries where 
screening quality and coverage have been high, Papanicolaou 
High prevalence of abnormal Pap smears among young 
women co-infected with HIV in rural South Africa – 
implications for cervical cancer screening policies in high 
HIV prevalence populations
Asheber Gaym, May Mashego, Ayesha B M Kharsany, Jenny Walldorf, Janet Frohlich, Quarraisha Abdool Karim
Objective. To establish the relationship between HIV infection 
and cervical dysplasia in young women in rural South  
Methods. This cross-sectional study was conducted at 
a primary health care clinic in Vulindlela, KwaZulu-
Natal. Standardised questionnaires were used to collect 
sociodemographic and clinical presentation data from 
women attending family planning and other reproductive 
health services.  Pap smears were done using standard 
methods.  Pap smear data were linked to HIV serostatus. 
Results. Four hundred and sixty-six women were included 
in the study. The median age was 24.3 years (range 15 - 55 
years), and 80% were younger than 30 years. The HIV preva- 
lence rate was 24.5% (95% confidence interval: 20.7 - 28.7%) 
and the prevalence of abnormal Pap smears was 16.9 - 6.4% 
ASCUS (atypical squamous cells of undetermined signifi-
cance), 9.2% LGSIL (low-grade squamous intraepithelial 
lesions), and 1.3% HGSIL (high-grade squamous  intraepithe 
lial lesions). The association between HIV seropositivity and 
abnormal Pap results was statistically significant (p < 0.05).    
Conclusion. There is a need for more data on cervical changes 
in HIV co-infected women and for review of guidelines 
on selective Pap smear screening in high HIV prevalence 
settings such as sub-Saharan Africa and where access to 
antiretroviral treatment remains limited.
S Afr Med J 2007; 97: 120-123.
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(Pap) screening efforts have reduced invasive cervical cancer 
incidence by about 70 - 90%.2  
High costs, lack of awareness and absence of adequate health 
infrastructure have prevented most low-resource countries from 
instituting population-wide Pap smear screening programmes. 
Only 5% of women in developing countries undergo cervical 
cancer screening compared with 40 - 50% in the developed 
world.3 Selective cervical cancer screening of women above 30 
years of age at least once in their lifetime has been suggested 
as an alternative Pap smear screening strategy in sub-Saharan 
Africa and other low-resource regions.4,5  
Several studies6-8 have found the prevalence of squamous 
intra-epithelial lesions (SILs) among HIV-positive women to 
be 31 - 63%. Further, the prevalence and degree of dysplasia 
increases with advancing levels of immunosuppression.9,10 The 
burden of HIV infection in sub-Saharan Africa among young 
women under the age of 30 years is increasing.11 While some 
clinicians working in Africa12,13 have expressed concern about 
younger age of cervical cancer presentation, little empirical data 
exist as to the reason for this and whether it is linked with the 
increasing burden of HIV infection in this region. 
The purpose of this study was to assess the relationship 
between Pap smear findings and HIV status in young women 
utilising family planning services in a high HIV prevalence set-
ting in rural South Africa.
Subjects and methods
This cross-sectional study was conducted between November 
2003 and April 2005 among young women utilising family plan-
ning services at the Mafakatini Clinic, Vulindlela district.   
Vulindlela is a rural district in the KwaZulu-Natal midlands, 
about 150 km west of Durban, with approximately 400 000 
residents. The Mafakatini Primary Health Care Clinic is one 
of seven such clinics providing comprehensive primary care 
services to this rural community. 
All women who presented to the clinic during the study pe-
riod for family planning and other reproductive health services 
and who consented to participation in the study were included.  
Sociodemographic and clinical variables including age, marital 
status, parity and sexual history (number of sexual partners) 
were collected after obtaining informed consent. 
A specimen from the cervix was obtained from each partici-
pant using the Ayre’s spatula. The specimen was smeared on 
a slide and fixed using Cytofix according to the conventional 
standard cytological screening procedure. Specimens were 
examined at the regional Department of Health cytopathology 
laboratories. The 1988 Bethesda II classification was used for 
reporting the Pap smear results.
 This study was reviewed and approved by the Nelson R 
Mandela School of Medicine Research Ethics Committee and 
permission to undertake this study was obtained from the 
KwaZulu-Natal Department of Health. Syndromic manage-
ment of sexually transmitted infections (STIs) was provided in 
accordance with the South African Department of Health guide-
lines.14 HIV-positive patients with indications for antiretroviral 
treatment were enrolled into the Centre for AIDS Programme of 
Research in South Africa (CAPRISA) Treatment Project. Patients 
with abnormal Pap smears were referred for further manage-
ment to the tertiary referral hospital for this district.  
Data were managed in Excel and analysed using the SPSS 
11.5 statistical package. 
Results
Sociodemographic characteristics
Of the 479 participants eligible for this study, 13 women 
consented to the Pap smear but refused HIV testing and were 
excluded from the analysis. The mean age of the 466 women 
included in this analysis was 24.3 years (standard deviation 
(SD) 7.0, range 15 - 55 years).  Most of the participants (76.0%) 
were single but had a stable sexual partner, 11.2% were single 
without a sexual partner, 7.3% were married and 4.9% were 
widowed. 
Most participants (52.2%) had completed high school, 43.1% 
were secondary school students, 4.3% had only completed 
primary school, and 0.4% had college education. 
Sexual behaviour, parity, contraception and condom 
use
Information was obtained on the number of sexual partners in 
the previous 6 months; 56.2% of participants reported hav-
ing only 1 partner, 12.4% reported having 3 partners and the 
remainder reported 2 to 6 partners. 
Parity of participants ranged from 1 to 7; 31.5% of partici-
pants were nulliparous and 47.7% were para 1. Depo-Provera 
injectable contraceptive was the most commonly used family-
planning method (60.1%), while 6.2% used combined hormonal 
pills for birth control, none of the participants used an intra-
uterine device or surgical sterilisation methods of contracep-
tion, 8.4% were not on any form of contraception, and 25.3% 
reported use of male condoms. 
HIV status and Pap smear results
Data on Pap smear results and HIV status are presented in 
Table I. The frequency of abnormal Pap smears was 16.9% 
(79/466).  LGSIL (low-grade squamous intraepithelial lesions) 
were the most common abnormality identified (9.2%), and 1.3% 
of the participants had HGSILs (high-grade squamous intraepi-
thelial lesions).  HIV status was not known for 13 participants. 
The HIV prevalence in this cohort was 24.5%.  There was a 
statistically significant association between HIV infection and 
abnormal Pap smear findings (10.3% among HIV-negative 
women v. 36% among HIV-positive women (chi-square 52.6, 
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p < 0.05; odds ratio (OR) 0.20, 95% confidence interval CI: 0.12 
- 0.34)). 
The age distribution of clients in relation to Pap smear results 
is presented in Table II. Overall age distribution of Pap smear 
results is similar within each age category. Of note is that almost 
all cases of HGSILs were detected in young women co-infected 
with HIV.  
Discussion 
The high prevalence of abnormal Pap smears in young sexually 
active women co-infected with HIV utilising family planning 
services in Vulindlela, KwaZulu-Natal, is of concern. While this 
is a fairly modest, cross-sectional study, it highlights the need 
for more studies of HIV-infected populations and a re-examina-
tion of criteria being used for cervical cancer screening in high 
HIV prevalence countries where the prevalence of cervical can-
cer is also high and access to antiretroviral treatment remains 
limited.   
All the HGSILs in this study occurred in women younger 
than 30 years of age, which is much lower than the usual age 
distribution for high-grade lesions (around 35 - 40 years of 
age).  Almost all cases of HGSILs occurred among HIV-infected 
women, suggesting a strong association between HIV infection 
and cytological changes. These findings are similar to those 
of other studies6,8,9 that have demonstrated a clear association 
between HIV infection and abnormal Pap smears. Management 
of HGSILs requires immediate follow-up with colposcopy-     
directed biopsy.
Higher HIV viral loads are associated with more efficient 
HIV transmission.15-17 A substantial increase in HIV shedding 
has been observed in HIV-positive women treated for pre-can-
cerous lesions.18 Counselling and HIV risk-reduction support 
for women after treatment of the pre-cancerous lesions is im-
portant. Abstinence and/or use of male condoms during coitus 
while the cervix heals is important to reduce both the risk of 
HIV transmission and exposure to HIV.
Data from other studies19-21 on further evaluation of ASCUS 
(atypical squamous cells of unknown significance) findings 
demonstrate a cervical intra-epithelial neoplasia (CIN)-1 rate of 
10 - 20%  and a CIN-2 and CIN-3 rate of 3 - 5%. CIN-2 and CIN-
3 have a 5% risk of progression to invasive cancer.18 Hence a 
finding of ASCUS on Pap smear signifies a small but significant 
morbidity risk to the patient.   
The prevalence of LGSILs reported in this study is substan-
tially higher than the 1.6 - 2.4% reported in the literature from 
population-based surveys.22 This higher rate could reflect the 
bias of the family planning population. A 20% association 
between LGSIL and CIN2/3 has been noted in other studies.22 
Hence women with LGSIL on Pap smear screening are likely to 
have a higher probability of progressing to invasive cancer than 
women with ASCUS results. The high rate of LGSIL among 
HIV co-infected young women found in this study needs fur-
ther investigation in similar settings as the high HIV prevalence 
in this age group could be reversing the age trends of cervical 
cytological abnormalities.
Recent cervical carcinoma studies23 demonstrate a 5 - 28% 
increase in the proportion of adenocarcinoma of the cervix com-
pared with squamous cell carcinoma.  Much of this increase is 
attributed to the high incidence of adenocarcinoma of the cervix 
in women in their 20s and 30s. Hence early detection of cervical 
adenocarcinoma using ASGUS (atypical glandular cells) in the 
Pap smears is becoming increasingly important24,25 and  needs 
to be understood better in resource-constrained settings with a 
high HIV prevalence.  As the majority of the lesions detected in 
these young women, who are ordinarily not screened because 
of the age selection criteria utilised, are early precursor lesions 
for cervical cancer, they lend themselves to intervention at an 
earlier stage thus potentially reducing individual and health-
sector costs.  
Worth noting is an important quality-limiting factor when 
Pap smears are taken using the Ayre’s spatula, viz. that a lim-
Table I.  HIV serostatus and Pap smear results for family planning clients in Vulindlela, KwaZulu-Natal, 2004/2005
  HIV-positive     HIV-negative  HIV?   Total
Pap smear results  (N)    (N)   (N)   (N)
Normal    73    304   10   387
ASCUS    12      18      0      30 
LGSIL    24       17      2      43 
HGSIL      5        0      1       6 
Total  114     339    13    464
Table II. Age distribution of Pap smear clients in 
Vulindlela, KwaZulu-Natal, 2004/2005
      Age group (years) 
Pap result 0 - 29             30 - 60  Total
Normal 313                73  386 
ASCUS   23                  7    30 
LGSIL   30                12    42 
HGSIL     5                  1     6 
Total 371                93  466 
Pearson’s chi-square = 2.460, p = 0.483.
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ited number of endocervical cells are collected. It is therefore 
possible that what we have identified in this study is an under-
estimate of the true prevalence of abnormal cervical lesions in 
this population. 
The high prevalence of HIV infection in young women may 
result in high incidence of cervical epithelial pathology in this 
subgroup of women thereby creating the need for expansion of 
the overall resources allocated for the cervical cancer screening 
programme.  
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